Session: 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI), Education
Objective: Documenting the experiences of patients with vaginal bleeding using qualitative methods and subsequently implement the findings using targeted multimodal knowledge-translation-exchange interventions including incorporation into medical education curricula.
Methods: Recruitment of self-identified women from St. Michael’s Hospital Hematology Clinic in Toronto, Ontario, Canada to elucidate narratives on the dimensions of vaginal bleeding-related experiences and healthcare interactions. Ethics was obtained through Unity Health Toronto Research Ethics Board (REB 21-126). Eligibility was determined by both clinical and self-reported heavy vaginal bleeding and complications. We used semi-structured interview guide informed by literature to conduct the interviews lasting 35 – 50 minutes using telecommunication to ensure we achieve thematic saturation. Interviews were audio-recorded, transcribed verbatim, with coding and thematic analysis completed.
Results: Analysis of n = 10 self-identified women with heavy vaginal bleeding with demographics yielding equitable distribution across race and ethnicity with 50% White women, 40% Black women, and 10% Asian women. At least 50% had a Bachelor’s degree and 20% had a Graduate degree. Duration of excessive bleeding was over 10 years for 90% of women with prolonged time to referral to specialist whether Hematology or Obstetrics/Gynecology for further evaluation. All participants experienced pain with heavy vaginal bleeding and were iron deficient as evidenced by iron supplementation whether oral or intravenous. Major themes include: shame around bleeding symptom, self-doubt, concerns of over-disclosing, normalization of heavy vaginal bleeding pathology which often led to delayed diagnoses and treatment, dismissal of symptoms disclosed leading to mistrust of healthcare system, and paradoxically the fear of “feeling better”.
Discussion: Heavy VBL is exceedingly common, has important clinical and psychosocial ramifications, yet it continues to be stigmatized, underdiagnosed, and thus poorly treated. Findings of our study indicate themes of shame, normalization of pathology, mistrust of healthcare systems, fear of feeling better. Structural sexism and discrimination lead to normalization, desensitization, dismissal and blame placement. Targeted knowledge translation rooted in theory- and evidence-based implementation science is urgently required in this space to break cycles of harm and injustice.
Disclosures: Lausman: Pfizer: Research Funding. Sholzberg: Octapharma: Research Funding; Pfizer: Research Funding.